Distribution of calcium-independent phospholipase A2 (iPLA 2) in monkey brain

Journal of Neurocytology

Volumn 34, Issue 6, 2006, Pages 447-458

  Ong, Wei Yi ^a   Yeo, Jin Fei ^a   Ling, Su Fung ^a   Farooqui, Akhlaq A ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PHOSPHOLIPASE A2;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CELL FRACTIONATION; CELL LABELING; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DENDRITE; DIENCEPHALON; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GLOBUS PALLIDUS; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOREACTIVITY; INFERIOR OLIVE; MALE; MESENCEPHALON; MONKEY; NEOCORTEX; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE ENDING; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; SIGNAL TRANSDUCTION; TELENCEPHALON; THALAMUS; TRIGEMINAL NUCLEUS; VESTIBULAR NUCLEUS; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL COMPARTMENTATION; CYTOSOL; DENDRITES; FEMALE; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NUCLEAR ENVELOPE; PHOSPHOLIPASES A; PRESYNAPTIC TERMINALS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; SUBCELLULAR FRACTIONS;

EID: 33747446287     PISSN: 03004864     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11068-006-8730-4     Document Type: Article

References (36)

1. 2 in nuclei of LA-N-1 neuroblastoma cells. Neurochemical Research 26, 83-88.
2. 2 and production of arachidonic acid in nuclei of LA-N-1 cell cultures: A specific receptor activation mediated with retinoic acid. Brain Research Molecular Brain Research 115, 187-95.
3. BRADFORD, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248-254.
4. 2. Journal of Lipid Mediators and Cell Signaling 12, 83-117.
5. 2 signaling in the nucleus. Brain Research Reviews 45, 179-195.
6. 2: A perspective on the history. Prostaglandins, Leukotrienes and Essential Fatty Acids 71, 161-169.
7. FAROOQUI, A. A., HORROCKS, L. A. & FAROOQUI, T. (2000a) Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chemistry and Physics of Lipids 106, 1-29.
8. FAROOQUI, A. A., HORROCKS, L. A. & FAROOQUI, T. (2000b) Deacylation and reacylation of neural membrane glycerophospholipids: Amatter of life and death. Journal of Molecular Neuroscience 14, 123-135.
9. 2 and its role in brain tissue. Journal of Neurochemistry 69, 889-901.
10. 2, PLC, and PLD of LA-N-1 cell nuclei. Reproduction, Nutrition and Development 45:613-631.
11. 2 activity in rat embryonic brain and in primary cultures of cortical neurons. Journal of Neural Transmission 109, 623-631.
12. 2 inhibitor in rat hippocampal slices. British Journal of Pharmacology 132, 1417-1422.
13. 2 inhibitor impairs spatial memory of mice. The Japanese Journal of Pharmacology 83, 277-278.
14. HORROBIN, D. F. (2003) Phospholipid and fatty acid biochemistry in schizophrenia. In Phospholipid Spectrum Disorders in Psychiatry and Neurology, 2nd edn, (edited by Peet, M., Glen, I., Horrobin, D. F.), pp 123-162, Marius Press, Lancashire, U.K.
15. 2and their effect on enzyme activity. Journal of Biological Chemistry 273, 207-214.
16. LEDEEN, R.W. & WU, G. (2004) Nuclear lipids: Key signaling effectors in the nervous system and other tissues. Journal of Lipid Research 45, 1-8.
17. 2 gene on chromosome 22q13.1. Journal of Biological Chemistry 274, 9607-9616.
18. MARTELLI, A. M., FALA, F., FAENZA, I., BILLI, A. M., CAPPELLINI, A., MANZOLI, L. & COCCO, L. (2004) Metabolism and signaling activities of nuclear lipids. Cellular and Molecular Life Sciences 61, 1143-1156.
19. 2: Its role in adaptive neural plasticity. Cellular and Molecular Life Sciences 57, 1542-1550.
20. MURAKAMI, K. & ROUTTENBERG, A. (2003) The role of fatty acids in synaptic growth and plasticity. In Phospholipid Spectrum Disorders in Psychiatry and Neurology, 2nd edn, (edited by Peet, M., Glen, I., Horrobin, D. F.), pp. 77-92. Marius Press, Lancashire, U.K.
21. 2 signaling pathway. Life Sciences 68, 2885-2891.
22. 2 in rat and monkey spinal cord. Journal of Molecular Neuroscience 12, 123-130.
23. 2 in the normal rat brain. Journal für Hirnforschung 39, 391-400.
24. RORDORF, G., KOROSHETZ, W. J. & BONVENTRE, J. V. (1991) Heat shock protects cultured neurons from glutamate toxicity. Neuron 7, 1043-1051.
25. 2-associated processes in the human brain and their role in neuropathology and psychopathology. In Phospholipid Spectrum Disorders in Psychiatry and Neurology, 2nd edn, (edited by Peet, M., Glen, I., Horrobin, D.F.), pp. 163-182. Marius Press, Lancashire, U.K.
26. 2. Archives of General Psychiatry 54, 487-494.
27. 2 activities in brain of patients with schizophrenia. Brain Research 821, 407-413.
28. 2 activity is required for nuclear shrinkage in caspase-independent cell death. The Journal of Cell Biology 163, 1219-1230.
29. 2 subtypes in rat cerebellum. Journal of Neurocytology 33, 297-307.
30. 2 activity in first but not in multiepisode chronic schizophrenia. Biological Psychiatry 57, 399-405.
31. 2 inhibitors selectively increases AMPA receptor-mediated synaptic transmission. Hippocampus 14, 319-325.
32. TAMIYA-KOIZUMI, K. (2002) Nuclear lipid metabolism and signaling. Journal of Biochemistry 132, 13-22.
33. 2. Federation of European Biochemical Societies Letters 377, 358-362.
34. 2. Analytical Biochemistry 269, 278-288.
35. 2from rat brain. Journal of Neurochemistry 73, 1278-1287.
36. 2inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 112, 148-155.